癌症相关认知障碍评估工具的范围综述

doi:10.3761/j.issn.0254-1769.2024.23.017

摘要/Abstract

摘要：

目的基于范围综述框架收集国内外癌症相关认知功能障碍评估工具，为此类评估工具的选择提供参考。方法系统检索了PubMed、Embase、Web of Science、中国知网、万方数据库、维普数据库等中英文数据库，检索时限为建库至2024年4月12日，提取文献和评估工具的基本信息，将检索结果进行规范化报告。结果共纳入31篇文献，其中26篇关于评估工具的开发或验证，5篇关于评估工具的本土化验证及应用，共涉及19个主观评估工具和8个客观评估工具。主观评估工具信效度检验多采用内部一致性信度检验和同时效度检验，14个主观评估工具为多维度量表，6个客观评估工具测量了重测信度，4个为单维度测量。结论目前相关研究选择的评估工具各不相同，建议选择国际认知和癌症工作组推荐的评估工具和判定标准开展相关研究，未来应进一步对现有癌症相关认知障碍评估工具进行验证和完善，并继续引入或研制本土化的癌症相关认知障碍评估工具。

关键词: 癌症相关认知障碍, 评估工具, 范围综述, 护理

Abstract:

Objective Based on the scoping review framework，we collected cancer-related cognitive impairment （CRCI） assessment tools from home and abroad to provide references for the standardized use of such assessment tools. Methods Chinese and English databases，such as Pubmed，Embase，Web of Science Core Collection database，CNIK，Wanfang database，and VIP database，were systematically searched from the establishment of the database to April 12，2024，to extract the basic information of evaluation tools，and the search results were standardized. Results 31 articles were included，of which 26 were about the development or validation of assessment tools，and 5 were about the localization and application of assessment tools，involving 19 subjective assessment tools and 8 objective assessment tools. Most of the subjective assessment tool reliability and validity tests were internal consistency reliability tests and concurrent validity tests；14 subjective assessment tools were multidimensional scales；6 objective assessment tools measured retest reliability；4 were unidimensional measures. Conclusion The assessment tools chosen for the current studies vary. It is recommended to choose the evaluation tools and judgment standards recommended by the International Cognitive and Cancer Working Group to carry out relevant research. In the future，the existing CRCI assessment tools should be further verified and improved，and a localized CRCI assessment tool should be continuously introduced or developed.

Key words: Cancer-Related Cognitive Impairment, Assessment Tools, Scoping Review, Nursing Care

饶淼, 韦荣泉, 李霞, 宁家杰, 王素婷, 蔡玉萍. 癌症相关认知障碍评估工具的范围综述[J]. 中华护理杂志, 2024, 59(23): 2919-2927.

RAO Miao, WEI Rongquan, LI Xia, NING Jiajie, WANG Suting, CAI Yuping. A scoping review of cancer related cognitive dysfunction assessment tools[J]. Chinese Journal of Nursing, 2024, 59(23): 2919-2927.

图/表 3

图1 文献筛选流程

Figure 1 Flow chart of literature screening

表1 癌症相关认知障碍主观评估工具的基本特征和信效度检验（n=19）

Table 1 Characteristics，reliability and validity test of subjective assessment tools for CRCI（n=19）

表2 癌症相关认知障碍客观评估工具的基本特征及信效度检验（n=8）

Table 2 Characteristics，reliability and validity test of objective assessment tools for CRCI（n=8）

参考文献 41

[1]	Lange M, Joly F, Vardy J, et al. Cancer-related cognitive impair-ment:an update on state of the art,detection,and management strategies in cancer survivors[J]. Ann Oncol, 2019, 30(12):1925-1940. DOI PMID
[2]	Craig CD, Monk BJ, Farley JH, et al. Cognitive impairment in gynecologic cancers:a systematic review of current approaches to diagnosis and treatment[J]. Support Care Cancer, 2014, 22(1):279-287.
[3]	Lange M, Lefevre Arbogast S, Hardy-Léger I, et al. Cognitive change in breast cancer patients up to 2 years after diagnosis[J]. J Natl Cancer Inst, 2023, 115(3):322-331.
[4]	Vardy J, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy:a review of published studies and recommendations for future research[J]. J Clin Oncol, 2007, 25(17):2455-2463.
[5]	王喜益, 叶志弘, 汤磊雯. 范围综述在护理领域的应用进展[J]. 中华护理杂志, 2019, 54(8):1259-1263. DOI URL
	Wang XY, Ye ZH, Tang LW. Application progress of scope review in nursing field[J]. Chin J Nurs, 2019, 54(8):1259-1263.
[6]	Martínez-Ramos N, Ávila L, Rodríguez S, et al. Attitudes scale toward cancer-related cognitive changes:an initial Colombian validation[J]. Eur Rev Med Pharmacol Sci, 2023, 27(16):7738-7748.
[7]	Liu H, Li YY, Li Y, et al. Psychometric properties of the Chinese version of the Cognitive Reserve Assessment Scale in health in patients with cancer[J]. BMC Psychiatry, 2023, 23(1):5. DOI PMID
[8]	徐培镕, 张焱, 孙倩男, 等. 中文版癌症患者功能评估-认知功能量表在胃肠肿瘤患者中的信效度检验和最佳界值研究[J]. 军事护理, 2023, 40(5):75-78.
	Xu PR, Zhang Y, Sun QN, et al. Psychometric evaluation of the Chinese version of Functional Assessment of Cancer Therapy-Cognitive Function among gastrointestinal tumor patients[J]. Mil Nurs, 2023, 40(5):75-78.
[9]	Hassan M, Barakat Z, Fares Y, et al. Cognitive functioning in women with breast cancer:psychometric properties of the Arabic version of the Functional Assessment of Cancer The-rapy-Cognitive Function Tool[J]. Health Qual Life Outcomes, 2023, 21(1):9.
[10]	Hajj A, Salameh P, Khoury R, et al. Psychometric properties of the 37-item Functional Assessment of Cancer Therapy-Cognitive Function(FACT-Cog) scale[J]. Future Oncol, 2022, 18(33):3741-3753.
[11]	Baghdadli A, Arcuri GG, Green CG, et al. The Fast Cognitive Evaluation(FaCE):a screening tool to detect cognitive impair-ment in patients with cancer[J]. BMC Cancer, 2023, 23(1):35. DOI PMID
[12]	Romero-Hernández AX, Galindo-Vázquez Ó, Penedo FJ, et al. Psychometric properties of the PROMIS^® v2.0 Cognitive Fun-ction Short Form (SF-8) in a Mexican cancer population[J]. Gaceta Mex De Oncol, 2023, 21(4):119-128.
[13]	Zarrella GV, Perez A, Dietrich J, et al. Reliability and validity of a novel cognitive self-assessment tool for patients with cancer[J]. Neurooncol Pract, 2021, 8(6):691-698. DOI PMID
[14]	Oort Q, Dirven L, Sikkes SAM, et al. Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours:phase Ⅰ-Ⅲ[J]. Qual Life Res, 2021, 30(5):1491-1502.
[15]	Jean-Pierre P, Cheng Y, Paxton RJ. Item-level psychometrics of a brief self-reported memory problem screening measure in breast cancer survivors[J]. Acta Oncol, 2020, 59(3):358-364. DOI PMID
[16]	Jean-Pierre P, Morrow GR, Mohile SG, et al. A brief patient self-report screening measure of cancer treatment-related memory problems:latent structure and reliability analysis[J]. Treat Strateg Oncol, 2011, 2(1):93-95.
[17]	Baumann E, Kuba K, Götze H, et al. Initial validation of the German version of the Attentional Function Index in a sample of haematological cancer survivors[J]. Eur J Cancer Care, 2020, 29(4):e13226.
[18]	Cimprich B, Visovatti M, Ronis DL. The Attentional Function Index:a self-report cognitive measure[J]. Psychooncology, 2011, 20(2):194-202.
[19]	Lai SC, Lin WC, Chen CH, et al. Development of a Taiwan Cancer-Related Fatigue Cognition Questionnaire:reliability and validity[J]. Oncotarget, 2017, 8(17):28880-28887.
[20]	Dorland HF, Abma FI, Roelen CA, et al. The Cognitive Symptom Checklist-Work in cancer patients is related with work func-tioning,fatigue and depressive symptoms:a validation study[J]. J Cancer Surviv, 2016, 10(3):545-552. DOI PMID
[21]	Ottati A, Feuerstein M. Brief self-report measure of work-related cognitive limitations in breast cancer survivors[J]. J Cancer Surviv, 2013, 7(2):262-273. DOI PMID
[22]	Ottensmeier H, Zimolong B, Wolff JE, et al. Neuropsychologi-cal short assessment of disease-and treatment-related intelli-gence deficits in children with brain tumours[J]. Eur J Pae-diatr Neurol, 2015, 19(3):298-307.
[23]	Sailors MH, Bodurka DC, Gning I, et al. Validating the M.D. Anderson Symptom Inventory(MDASI) for use in patients with ovarian cancer[J]. Gynecol Oncol, 2013, 130(2):323-328. DOI PMID
[24]	Krull KR, Gioia G, Ness KK, et al. Reliability and validity of the Childhood Cancer Survivor Study Neurocognitive Question-naire[J]. Cancer, 2008, 113(8):2188-2197.
[25]	Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30:a quality-of-life instrument for use in international clinical trials in oncology[J]. J Natl Cancer Inst, 1993, 85(5):365-376. DOI PMID
[26]	van Dyk K, Ganz PA, Ercoli L, et al. Measuring cognitive com-plaints in breast cancer survivors:psychometric properties of the patient’s assessment of own functioning inventory[J]. Sup-port Care Cancer, 2016, 24(12):4939-4949.
[27]	Gaynor AM, Ahsan A, Jung D, et al. Novel computerized neu-rocognitive test battery is sensitive to cancer-related cognitive deficits in survivors[J]. J Cancer Surviv, 2024, 18(2):466-478.
[28]	Bellens A, Roelant E, Sabbe B, et al. Evaluation of a new online cognitive assessment tool in breast cancer survivors with cognitive impairment:a prospective cohort study[J]. Support Care Cancer, 2022, 30(1):21-31.
[29]	Valentine TR, Weiss DM, Jones JA, et al. Construct validity of PROMIS Cognitive Function in cancer patients and noncan-cer controls[J]. Health Psychol, 2019, 38(5):351-358. DOI PMID
[30]	Woods SP, Delis DC, Scott JC, et al. The California Verbal Learning Test:second edition:test-retest reliability,practice effects,and reliable change indices for the standard and alternate forms[J]. Arch Clin Neuropsychol, 2006, 21(5):413-420.
[31]	de Sousa Magalhães S, Fernandes Malloy-Diniz L, Cavalheiro Hamdan A. Validity convergent and reliability test-retest of the Rey Auditory Verbal Learning Test[J]. Clinical Neuropsychi-atry, 2012, 9(3).
[32]	O’Neil-Pirozzi TM, Goldstein R, Strangman GE, et al. Test-re-test reliability of the Hopkins Verbal Learning Test-Revised in individuals with traumatic brain injury[J]. Brain Inj, 2012, 26(12):1425-1430.
[33]	Berry DTR, Allen RS, Schmitt FA. Rey-Osterrieth complex figure:psychometric characteristics in a geriatric sample[J]. Clin Neu-ropsychol, 1991, 5(2):143-153.
[34]	Wechsler D. Wechsler Adult Intelligence Scale:third edition[M]. San Antonio, TX: Pearson; 2008.
[35]	Levine AJ, Miller EN, Becker JT, et al. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments[J]. Clin Neuropsychol, 2004, 18(3):373-384. PMID
[36]	Arcuri GG, Palladini L, Dumas G, et al. Exploring the mea-surement properties of the Montreal Cognitive Assessment in a population of people with cancer[J]. Support Care Cancer, 2015, 23(9):2779-2787.
[37]	Wefel JS, Vardy J, Ahles T, et al. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer[J]. Lancet Oncol, 2011, 12(7):703-708. DOI PMID
[38]	王丽英, 丁焱, 张易, 等. 卵巢癌患者癌症相关性认知功能障碍现状及影响因素分析[J]. 中华护理杂志, 2023, 58(14):1726-1732. DOI URL
	Wang LY, Ding Y, Zhang Y, et al. The status and influen-cing factors of cancer-related cognitive impairment in patients with ovarian cancer[J]. Chin J Nurs, 2023, 58(14):1726-1732.
[39]	Apple AC, Schroeder MP, Ryals AJ, et al. Hippocampal func-tional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy[J]. Neuroimage Clin, 2018,20:110-118.
[40]	黄思婷, 余鑫源, 巫雨轩, 等. 结直肠癌患者认知功能障碍研究热点的共词聚类分析[J]. 中华护理杂志, 2023, 58(2):211-216. DOI URL
	Huang ST, Yu XY, Wu YX, et al. Co-word clustering analysis of cognitive dysfunction research hotspots in colorectal cancer patients[J]. Chin J Nurs, 2023, 58(2):211-216. DOI URL
[41]	叶磊, 夏广惠, 陈方梅, 等. 虚拟现实技术在癌症相关认知障碍患者中应用的范围综述[J]. 中华护理杂志, 2024, 59(7):882-889. DOI URL
	Ye L, Xia GH, Chen FM, et al. A scoping review of virtual reality on the effects on patients of cancer-related cognitive impairment[J]. Chin J Nurs, 2024, 59(7):882-889. DOI URL